European Medicines Agency Accepts Marketing Authorization Application for Dalbavancin
December 23, 2013European Medicines Agency Accepts Marketing Authorization Application for Dalbavancin
More »
Clinical Studies Demonstrate Feasibility and Accuracy of the Harmony™ Prenatal Test for Risk Assessment of Down Syndrome in Twin Pregnancies
December 19, 2013The two studies published in Fetal Diagnosis and Therapy provide information on how to consider use of non-invasive prenatal testing (NIPT) with cell-free DNA (cfDNA) in identical (monozygotic) and fraternal (dizygotic) twin pregnancies.
More »
Atara Biotherapeutics Secures $38.5 Million Series B Financing
December 17, 2013Proceeds will be used to accelerate the clinical development of Atara’s two lead programs, PINTA 745 and STM 434, in muscle wasting and cancer, respectively, which are expected to generate new clinical data within the next 18 months.
More »